TSP-21614-90576
4 vaccinations
3 coded responses
42 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 850 / AZ
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Nasopharyngitis — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Short period of mild head cold feelingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Headache, Sleep disorder — Feeling: Good · HeadacheFree text: Unsure if related. Headache that woke me up at 0200. Ended up needing to take ibuprofen and it went away. No issues since then.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-22
- 2020-12-26
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-02-01
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-09-29
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Mild ancillary lymphadenopathy on injection sideMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-15
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-12-29
- 2022-03-30
- 2022-09-29
-
2022-11-21
Dose 4 — Moderna
- 2022-12-17
- 2022-12-19
- 2022-12-26
- 2023-01-02
- 2023-02-20
- 2023-05-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-11-21 | Moderna | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Short period of mild head cold feeling
Systemic reaction (other): Unsure if related. Headache that woke me up at 0200. Ended up needing to take ibuprofen and it went away. No issues since then.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Mild ancillary lymphadenopathy on injection side
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Nasopharyngitis | ✓ | ✓ | ✓ |
| SRO | Sleep disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release